Serologicals Corporation Third Quarter 2005 Earnings Conference Call

Serologicals Corporation (NASDAQ:SERO) announced today
that it will release its third quarter earnings on Thursday, October
27, 2005 after the close of regular trading hours, and then host a
conference call on Friday, October 28, 2005 at 11:00 a.m. (ET) to
review the results.
   The conference call dial-in number is 888-396-2384, International
dial-in 617-847-8711, confirmation code 13958054. The live broadcast
will also be available online at the Company's website at
www.serologicals.com and at www.StreetEvents.com.
   If you are unable to participate in the call, a 14-day playback
will start October 28, 2005 at 1:00 p.m. (Eastern Time). To listen to
the playback, please call 888-286-8010, International dial-in
617-801-6888, and enter access code 27440165, or access the archived
web cast on the Company's website at www.serologicals.com.

   Serologicals Corporation (NASDAQ:SERO), headquartered in Atlanta,
GA., is a global leader in developing and commercializing consumable
biological products, enabling technologies and services in support of
biological research, drug discovery, and the bioprocessing of life-
enhancing products. Our customers include researchers at major life
science companies and leading research institutions involved in key
disciplines, such as neurology, oncology, hematology, immunology,
cardiology, proteomics, infectious diseases, cell signaling and stem
cell research. In addition, Serologicals is the world's leading
provider of monoclonal antibodies for the blood typing industry.
   Serologicals employs a total of more than 1,000 people worldwide
in three Serologicals' companies: Chemicon International,
headquartered in Temecula, CA, Upstate Group, LLC, headquartered in
Charlottesville, VA. and Celliance Corporation, headquartered in
Atlanta, GA.

   For more information, please visit our website:
www.serologicals.com

   Serologicals is a registered trademark of Serologicals Royalty
Company.